We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
+$23.5M
Cap. Flow
+$20.7M
Cap. Flow %
14.77%
Top 10 Hldgs %
45.63%
Holding
53
New
9
Increased
27
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$2.77M
2
SAGE
Sage Therapeutics
SAGE
+$2.74M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.66M
4
XLRN
Acceleron Pharma
XLRN
+$2.65M
5
IFRX icon
InflaRx
IFRX
+$2.39M

Top Sells

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$1.88M
2
BKR icon
Baker Hughes
BKR
+$1.87M
3
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$1.84M
4
TSRO
TESARO, Inc.
TSRO
+$1.69M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.68M

Sector Composition

Rank Sector Weight
1 Healthcare 53.45%
2 Financials 29.17%
3 Consumer Discretionary 3.76%
4 Technology 3.25%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
51
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-518,223
Closed -$1.49M
TSRO
52
DELISTED
TESARO, Inc.
TSRO
– –
-20,407
Closed -$1.69M
AAAP
53
DELISTED
Advanced Accelerator Applications S.A.
AAAP
– –
-22,538
Closed -$1.84M
1 2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q1 2018 Portfolio in Review

As of Q1 2018, Emory University held 53 positions worth $140M, up 20% from $117M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Emory University deployed $20.7M of net new capital in Q1 2018, opening 9 new positions and adding to 27 existing holdings. Its largest new stake was Blueprint Medicines: 32,163 shares worth $2.95M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 45% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Wave Life Sciences, an estimated $636K trimmed.

  • Emory University's largest Q1 2018 buy was Blueprint Medicines: 32,163 shares worth $2.95M.
  • Emory University added most to Puma Biotechnology in Q1 2018, an estimated $1.65M increase.
  • Emory University's biggest Q1 2018 reduction was Wave Life Sciences, cutting an estimated $636K.
  • Emory University fully exited BioCryst Pharmaceuticals in Q1 2018, selling an estimated $1.88M.
  • Emory University's ten largest holdings make up 46% of its $140M portfolio in Q1 2018.
  • Emory University opened 9 new positions and closed 7 in Q1 2018.
  • Emory University's portfolio value rose 20% quarter-over-quarter to $140M.

Based on Emory University's 13F filing for Q1 2018, filed 14 May 2018.